Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/23/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Richard D. Klausner

Wrong Dr. Richard D. Klausner?

Senior Vice President and Chief M...

Phone: (858) ***-****  HQ Phone
Illumina , Inc.
9885 Towne Centre Drive
San Diego, California 92121
United States

Company Description: Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function. The...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • undergraduate degree
    Yale University
  • medical degree
    Duke University
  • MD
193 Total References
Web References
Juno Therapeutics |
junotherapeutics.com, 19 Aug 2014 [cached]
DR. RICHARD KLAUSNER
...
DR. RICHARD KLAUSNER
Director and Co-founder
Dr. Klausner is currently Senior Vice President and Chief Medical Officer of Illumina Corporation. He is also chairman of Audax Health. Previously, he has served as managing partner of the venture capital firm, The Column Group, was the Executive Director for Global Health of the Bill and Melinda Gates Foundation and was the eleventh director of the National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the cell biology and metabolism branch of the National Institute of Child Health and Human Development as well as a past president of the American Society of Clinical Investigation. He has also been Chairman of the National Science Education Standards Projects of the National Academy of Sciences. He is the Chief Strategy Advisor for USAID and has served in senior advisory roles to the US, Norwegian, Qatari and Indian governments. He currently chairs the International Advisory Board for Samsung and previously chaired the Strategic Oversight Council of Sanofi. He currently serves on numerous advisory boards.
Dr. Klausner is well known for his work in cell and molecular biology, and has been the author of more than 300 scientific articles and several books, in addition to receiving numerous awards and honors. He has served as an Advisor to the Presidents of the Academies for counter-terrorism, and Liaison to the White House Office of Science & Technology Policy. He is a member of the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences.
Rick Klausner, ...
www.bioresearchonline.com, 25 Aug 2014 [cached]
Rick Klausner, Illumina's CMO, said, "Illumina is developing a universal test system to support our partners' oncology drug pipelines. We're excited to be working together with companies such as AstraZeneca, and other bodies, to maximize genomic medicine benefits to patients. Klausner shared that the company will be a key player in a new genome initiative launched by the U.K. government.
Richard Klausner, M.D., ...
www.fhcrc.org, 4 Dec 2013 [cached]
Richard Klausner, M.D., co-founder of Juno and former director of the National Cancer Institute, added, "In more than 30 years of immunotherapy research, this is the most exciting data I've seen-a complete molecular response in clinical trial patients."
...
Richard Klausner, M.D., former director of the National Cancer Institute; and
Health Care Concepts (HCC)
www.hcc1.com, 30 April 2002 [cached]
(12/19/01) Klausner Accepts Position as National Academies' Adviser on Counterterrorism -- Beginning Jan. 1, 2002, Richard D. Klausner will assume the post of senior fellow and special adviser to the presidents for counterterrorism at the National Academies.The Academies are actively engaged in facilitating a more focused and coordinated involvement of the science and technology community in assessing threats, developing countermeasures, and designing responses to terrorist attacks.As former director of the National Cancer Institute and a member of both the National Academy of Sciences and the Institute of Medicine, Klausner will use his extensive ties to both the U.S. government and the scientific community to help the Academies bring the best science and technology expertise to bear on increasing homeland security.
Additional founders of Juno ...
www.mskcc.org, 20 July 2014 [cached]
Additional founders of Juno are Fred Hutchinson President and Director Larry Corey as well as Philip Greenberg, head of Fred Hutchinson's Immunology Program and Stanley Riddell, a member of its Clinical Research Division; Michael Jensen, Director of the Ben Towne Center for Childhood Cancer Research at Seattle Children's Research Institute; Richard Klausner, former director of the National Cancer Institute; and Robert Nelson, co-founder and managing director of ARCH Venture Partners.
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304